STOCK TITAN

Embecta Corp - EMBC STOCK NEWS

Welcome to our dedicated news page for Embecta (Ticker: EMBC), a resource for investors and traders seeking the latest updates and insights on Embecta.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Embecta's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Embecta's position in the market.

Rhea-AI Summary
Embecta Corp. sponsors a symposium at the ATTD conference focusing on insulin pump therapy for T2D care, showcasing six scientific posters. The event aims to enhance informed decision-making for patients with type 2 diabetes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Embecta Corp. (EMBC) reports strong financial results for the first quarter of fiscal year 2024, with revenues of $277.3 million and various key financial metrics exceeding expectations. The company made progress on strategic priorities, including the 510(k) filing of an open-loop patch pump with the FDA. Despite a slight decrease in U.S. revenues, international revenues saw an increase. The company raised its guidance for certain financial metrics for the year. Embecta also announced a dividend of $0.15 per share.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.47%
Tags
earnings
-
Rhea-AI Summary
Embecta Corp. (EMBC) has announced a quarterly cash dividend of $0.15 per share for its common stock, payable on March 15, 2024. The dividend is for stockholders of record as of February 28, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.47%
Tags
dividends
Rhea-AI Summary
Embecta Corp. (EMBC) will host one-on-one investor meetings on February 13, 2024, at the Cliff Lodge, Snowbird, UT. The company aims to engage with investors and provide updates on its business operations and financial performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
conferences
-
Rhea-AI Summary
Embecta Corp. will host a conference call to discuss its fiscal first quarter 2024 financial results and provide an operational update on February 9, 2024. The company has a 100-year legacy in insulin delivery and invites participants to access the live webcast or teleconference. A webcast replay will also be available on the company's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
conferences earnings
-
Rhea-AI Summary
Embecta Corp. (EMBC) announces the submission of a 510(k) premarket filing to the FDA for a proprietary disposable insulin delivery system, addressing the needs of people with type 2 diabetes. The company aims to provide a simplified and convenient option for automated insulin delivery, offering a larger 300U insulin reservoir, and plans to develop a closed-loop version with an insulin-dosing algorithm in the future.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.45%
Tags
none
Rhea-AI Summary
Embecta Corp. (EMBC) to Present at J.P. Morgan Healthcare Conference on January 10, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.02%
Tags
conferences
-
Rhea-AI Summary
Embecta Corp. (EMBC) issues a statement regarding the U.S. FDA Safety Communication on plastic syringes, clarifying that the notice only applies to products made in China and has no impact on their production or sale. The company emphasizes its 100-year legacy of quality and innovation, assuring customers of its commitment to healthcare.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
none
-
Rhea-AI Summary
Embecta Corp. (EMBC) to participate in investor events at 2023 Mizuho Medical Device and Healthcare Services Summit and 2023 MedTech Madness Annual West Coast Bus Tour
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
conferences
Rhea-AI Summary
Embecta Corp. (EMBC) reported financial results for the fiscal year 2023, showing better than expected performance during each quarter, with strong performance in the fiscal fourth quarter. The company's strategic priorities include investing in the development of a type 2 closed loop insulin delivery system.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.47%
Tags
earnings
Embecta Corp

Nasdaq:EMBC

EMBC Rankings

EMBC Stock Data

742.77M
53.21M
0.48%
98.58%
5.39%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Parsippany